Related references
Note: Only part of the references are listed.Imaging techniques: new avenues in cancer gene and cell therapy
Z. Saadatpour et al.
CANCER GENE THERAPY (2017)
Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes
Sasagu Kurozumi et al.
JOURNAL OF HUMAN GENETICS (2017)
KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer
Takuya Nagata et al.
BREAST CANCER (2017)
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2017)
Molecular Imaging and Oral Cancer Diagnosis and Therapy
Maryam Keshavarzi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?
Hamed Mirzaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
MicroRNA-200c and microRNA-141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer
Guangxin Zhang et al.
BREAST CANCER RESEARCH (2017)
Green tea and its anti-angiogenesis effects
Bahman Rashidi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia
S. Fathullahzadeh et al.
CANCER GENE THERAPY (2016)
Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma
M. Mohammadi et al.
CANCER GENE THERAPY (2016)
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers
L. Saadatpour et al.
CANCER GENE THERAPY (2016)
Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives
Hamed Mirzaei et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Xiaofeng Dai et al.
JOURNAL OF CANCER (2016)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
Cailu Song et al.
SCIENTIFIC REPORTS (2016)
Plasma exosome microRNAs are indicative of breast cancer
Bethany N. Hannafon et al.
BREAST CANCER RESEARCH (2016)
Amperometric magnetoimmunosensor for ErbB2 breast cancer biomarker determination in human serum, cell lysates and intact breast cancer cells
U. Eletxigerra et al.
BIOSENSORS & BIOELECTRONICS (2015)
Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
Lei Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging
Sunitha V. Bachawal et al.
CANCER RESEARCH (2015)
Role of microRNAs-29b-2,-155,-197 and-205 as diagnostic biomarkers in serum of breast cancer females
Olfat Shaker et al.
GENE (2015)
Comparing Different Ultrasound Imaging Methods for Breast Cancer Detection
Neslihan Ozmen et al.
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL (2015)
MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer
Sanaa Eissa et al.
TUMOR BIOLOGY (2015)
Assessment of Estrogen Receptor Expression in Epithelial Ovarian Cancer Patients Using 16α-18F-Fluoro-17β-Estradiol PET/CT
Michel van Kruchten et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
Marek Sochor et al.
BMC CANCER (2014)
Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: Correlation with biological factors
Wan-Ru Jia et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
Gangping Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Computer-aided detection of breast cancer on mammograms: A swarm intelligence optimized wavelet neural network approach
J. Dheeba et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2014)
Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression
Carla J. Beckham et al.
JOURNAL OF UROLOGY (2014)
Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer
In Hae Park et al.
TUMOR BIOLOGY (2014)
Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
Jie Shen et al.
ONCOTARGET (2014)
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
Jessica Bockhorn et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
Chun-Wen Cheng et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A comparison of the accuracy of film-screen mammography, full-field digital mammography, and digital breast tomosynthesis
M. J. Michell et al.
CLINICAL RADIOLOGY (2012)
The RGD finger of Del-1 is a unique structural feature critical for integrin binding
Thomas Schuerpf et al.
FASEB JOURNAL (2012)
MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
Fengyan Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
A. L. Smith et al.
ONCOGENE (2012)
Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland
R. L. Bennett et al.
BRITISH JOURNAL OF CANCER (2011)
Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells
Aamir Ahmad et al.
CANCER RESEARCH (2011)
Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram
Paulo Almazy Zanello et al.
CLINICS (2011)
Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies
Anne-Sofie Schrohl et al.
HISTOPATHOLOGY (2011)
p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs
Chun-Ju Chang et al.
NATURE CELL BIOLOGY (2011)
UWB MICROWAVE IMAGING FOR BREAST CANCER DETECTION - EXPERIMENTS WITH HETEROGENEOUS BREAST PHANTOMS
J. C. Y. Lai et al.
PROGRESS IN ELECTROMAGNETICS RESEARCH M (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Oncogenic Wip1 Phosphatase Is Inhibited by miR-16 in the DNA Damage Signaling Pathway
Xinna Zhang et al.
CANCER RESEARCH (2010)
Current and emerging biomarkers in breast cancer: prognosis and prediction
Marion T. Weigel et al.
ENDOCRINE-RELATED CANCER (2010)
Estrogen Stimulation of Cell Migration Involves Multiple Signaling Pathway Interactions
Yan Li et al.
ENDOCRINOLOGY (2010)
Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
Francesco Sardanelli et al.
EUROPEAN JOURNAL OF CANCER (2010)
Digital breast tomosynthesis versus digital mammography: a clinical performance study
Gisella Gennaro et al.
EUROPEAN RADIOLOGY (2010)
A Pilot Study of Circulating miRNAs as Potential Biomarkers of Early Stage Breast Cancer
Hua Zhao et al.
PLOS ONE (2010)
High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients
Jian-Cong Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-EnhancedMR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?
Siwa Chan et al.
JOURNAL OF ONCOLOGY (2010)
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer
M. Kioulafa et al.
ANNALS OF ONCOLOGY (2009)
Projected Cancer Risks From Computed Tomographic Scans Performed in the United States in 2007
Amy Berrington de Gonzalez et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Autoantibody to Tumor Antigen, Alpha 2-HS Glycoprotein: A Novel Biomarker of Breast Cancer Screening and Diagnosis
Jae Kyo Yi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Sperm-Associated Antigen 9, a Novel Biomarker for Early Detection of Breast Cancer
Deepika Kanojia et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
Ariane Sadr-Nabavi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
Corina Kohler et al.
MOLECULAR CANCER (2009)
TMEM25, REPS2 and Meis 1: Favourable Prognostic and Predictive Biomarkers for Breast Cancer
P. Doolan et al.
TUMOR BIOLOGY (2009)
Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer
Eiji Sunami et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
ER alpha suppresses slug expression directly by transcriptional repression
Yin Ye et al.
BIOCHEMICAL JOURNAL (2008)
Quantitative detection of methylated ESR1 and 14-3-3-σ gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy
Joaquina Martinez-Galan et al.
CANCER BIOLOGY & THERAPY (2008)
Urinary metalloproteinases: Noninvasive biomarkers for breast cancer risk assessment
Susan E. Pories et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis
Patrizia Pasanisi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
TBX3 is overexpressed in breast cancer and represses p14ARF by interacting with histone deacetylases
Will Yarosh et al.
CANCER RESEARCH (2008)
Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer
Raquel Catarino et al.
DNA AND CELL BIOLOGY (2008)
Breast MRI: guidelines from the European Society of Breast Imaging
R. M. Mann et al.
EUROPEAN RADIOLOGY (2008)
Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer
Rachel F. Brem et al.
RADIOLOGY (2008)
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
Jong Wook Chang et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E. de Azambuja et al.
BRITISH JOURNAL OF CANCER (2007)
Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies
Galit Eliyahu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker
Linda H. Malkas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer
Elizabeth E. Evans et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Metallothionein as a prognostic biomarker in breast cancer
Boon-Huat Bay et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2006)
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
Michael D. Mattie et al.
MOLECULAR CANCER (2006)
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer
A Gil-Rendo et al.
BRITISH JOURNAL OF SURGERY (2006)
Serum biomarkers for detection of breast cancers: a prospective study
C Mathelin et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer
R Kumar et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli
C Garofalo et al.
CLINICAL CANCER RESEARCH (2006)
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis
R Mehra et al.
CANCER RESEARCH (2005)
Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid
JN Li et al.
CLINICAL CANCER RESEARCH (2005)
The HCCR oncoprotein as a biomarker for human breast cancer
SS Jung et al.
CLINICAL CANCER RESEARCH (2005)
Diagnostic performance of digital versus film mammography for breast-cancer screening
ED Pisano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy
Q Pan et al.
CANCER RESEARCH (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer
T Uematsu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2005)
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography
F Benard et al.
BREAST CANCER RESEARCH (2005)
Oestrogen receptor β:: what it means for patients with breast cancer
V Speirs et al.
LANCET ONCOLOGY (2004)
Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D
A Ström et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: A report of the staging breast cancer with PET study group
RL Wahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Diagnostic delay in breast cancer
MD Barber et al.
BRITISH JOURNAL OF SURGERY (2004)
Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
H Yamashita et al.
BREAST CANCER RESEARCH (2004)
Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model
GP Skliris et al.
JOURNAL OF PATHOLOGY (2003)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
MTA3, a Mi-2/NuRD complex subunit, an invasive growth pathway in breast
N Fujita et al.
CELL (2003)
Use of serological proteomic methods to find biomarkers associated with breast cancer
R Zhao et al.
PROTEOMICS (2003)
The embryonic angiogenic factor Del1 accelerates tumor growth by enhancing vascular formation
Y Aoka et al.
MICROVASCULAR RESEARCH (2002)
Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53
SW Beenken et al.
ANNALS OF SURGERY (2001)
Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection
RL Birdwell et al.
RADIOLOGY (2001)
MR imaging: Breast cancer staging and screening
K Kinkel et al.
SEMINARS IN SURGICAL ONCOLOGY (2001)
BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer
BC Turner et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Prognostic and predictive significance of ErbB-2 breast tumor levels measured by enzyme immunoassay
S Eppenberger-Castori et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer
TAH Jarvinen et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
